Expert Panel Page 76

Top Stories in Expert Panel

Cost Increases Within Canadian Drug Plans: What’s the Real Story?

Some plan sponsors we have worked with over the past year in considering their 2007 and 2008 claims experiences have seen inflation rates within their…

  • April 20, 2009 September 13, 2019
  • 00:00

The Financial Fallout of Bill 102 on Private Sector Drug Plans

Depending on your perspective, and what stakeholder group you belong to, you may not like what the provincial government in Ontario has done with its…

  • February 23, 2009 September 13, 2019
  • 00:00

Drug Claims Data: The Duct Tape of Group Benefits

The Wikipedia definition of duct tape references that the product’s “strength and remarkable versatility make it a household staple throughout North America for general-purpose use.”…

  • December 29, 2008 September 13, 2019
  • 00:00

Experts Abound

The report and recommendations of the Ontario Expert Commission on Pensions were released November 20, 2008. The Commission’s mandate, while not explicitly stated as such,…

  • December 19, 2008 September 13, 2019
  • 00:00

Drug Pricing Discrepancies in Canada

There are some profound drug pricing discrepancies in existence within private sector drug plans that highlight the driving forces behind the end of the existing…

  • October 15, 2008 September 13, 2019
  • 00:00

Shock Markets

The past few weeks has been eventful, to say the least. We have watched the disappearance of Lehman Brothers and the changing status of Goldman…

  • October 8, 2008 September 13, 2019
  • 00:00

Which is Better: DB or DC?

There is always much debate about whether being part of a defined benefit (DB) or defined contribution (DC) pension plan is better. People who wish…

  • August 6, 2008 September 13, 2019
  • 00:00

Private Plan Sponsors are Losing the Race

There are not very many areas with respect to operating a business where governments are light years ahead of the private sector, but the management…

  • July 30, 2008 September 13, 2019
  • 00:00

The Myths of High Users within the Prescription Drug Plan

In this era of wonderful, innovative drug products that treat debilitating conditions like rheumatoid arthritis, cancer and multiple sclerosis, many of us have been conditioned…

  • May 26, 2008 September 13, 2019
  • 00:00

The Flattening World of Money Management

Every 18 months or so, those of us who do manager research at Watson Wyatt get together on a global basis to discuss new approaches…

  • May 21, 2008 September 13, 2019
  • 00:00

Math: The Best Benefit Plan Review Tool Available

One scenario that I have seen play itself out on multiple occasions over the past year is that of a plan sponsor trying to understand…

  • March 19, 2008 September 13, 2019
  • 00:00

Bond Ambition

You may read the title of this article and think that I am going to write about James Bond, 007. Sorry to say this article…

  • March 12, 2008 September 13, 2019
  • 00:00

Drug Plans in 2008 and Beyond

It’s hard to believe we are already into a new year. Fiscal and strategic planning for the new calendar year have been completed. It’s now…

  • January 9, 2008 September 13, 2019
  • 00:00